Navigation Links
Hard to Treat Diseases, Inc. (HTDS) Thai Registration Dossier
Date:7/31/2009

SHENZHEN, China, July 31 /PRNewswire-FirstCall/ - Hard to Treat Diseases, Inc. (HTDS:PK), http://www.htdsmedical.com announced today that its registration dossier for MEVAC-DTaP (Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, adsorbed) had passed the preliminary consideration of the experts in Thai FDA. The sample analysis is expected to be completed within the next 30 days.

Mr. Terry Yuan CEO of HTDS said (sic) "We welcome the expanded role of the medical team in Serbia. There has been a great synergy between the medical group in Serbia and us here in China, right from day one. I have great admiration for the work they are doing which is simply amazing. It is our goal and target to see the fruits of our labour begin to pay off for us and all of our shareholders.

HTDS was a company acquired by the new management, with the backing of our financiers' under duress, just less than a year ago. Many of HTDS long time shareholders basically witnessed HTDS share values dwindle down to next to nothing. Our goal is to reverse that trend and we believe we are well under way. We have received a number of inquiries about an open Regulation D financing and filing we did. HTDS is a medical company engaged in both RD and vaccine distribution as its core business. Over the next several weeks and months we will be issuing many updates as to what progress the company made. By that we mean, how this financing was used, what equipment was acquired, contracts signed and what assets were acquired, and more importantly the forward strides we made as a company. Our days of being under duress and in peril are well behind us now.

Today, in less than a year we have two very vibrant companies in HTDS. We are focused, determined and the two companies are working hard and there is great synergy and sync between us all. The Mellow Hope division generates
'/>"/>

SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cancer Survivors Face Tough Road Long After Treatment Ends
2. Judge Sues Blue Cross for Autism Treatment
3. FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
4. Living Green Marketplace Announces the Cancer Care Wellness Box to Bring Comfort to Cancer Patients During Medical Treatment
5. New Spanish-Language Consumer Guides Compare Treatments for Depression, Prostate Cancer and Other Conditions
6. Alternative Therapies for Fighting Eczema Hold Promise, But Dermatologists Caution They Are No Substitute for Proven Medical Treatments
7. New Laser Treatment for Cellulite Helps Fight the Battle
8. New BioTrends Report Explores Anticipated Treatment Pattern Shifts Expected with the Proposed Bundled Payment Structure Planned for 2011
9. NHLBI stops study of pulmonary hypertension treatment in sickle cell patients
10. New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants
11. Hard to Treat Diseases (HTDS) To Re Release European TV Segment In N. America For Potential Treatment Of MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 As interest in the value of ... momentum worldwide, Rev. Eric J. Hall , president and ... (HCCN), will be the keynote speaker on January 27 at ... health system. , The conference, “Hope and Resilience: Innovative and ...
(Date:1/22/2015)... 22, 2015 Compare-autoinsurance.org has released a new blog ... an auto insurance policy . , Some types of ... should check the newly released blog post to see if their ... dangerously damaged vehicles are some of the cars that cannot be ...
(Date:1/22/2015)... 22, 2015 Step into a macabre ... Science Museum of Virginia. Wicked Plants, the Museum’s latest ... unearths 75 poisonous, carnivorous and diabolical plants inside of ... to uncover the biochemical, physical and neurological processes between ...
(Date:12/26/2014)... The US represents the largest market for ... GlobalData’s forecast estimates that sales of branded therapies were $2.23 ... the high incidence of the disease, high drug treatment rate, ... China. Increased sales of CRC therapies over the forecast period ...
(Date:12/26/2014)... December 26, 2014 Cooking and warming ... of 5. This score reflects slightly positive negotiation conditions for ... switching costs and a low level of price volatility. “However, ... for cooking and warming equipment and high volatility in the ...
Breaking Medicine News(10 mins):Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3
... BATON ROUGE A major concern related to the Deepwater ... living in coastal areas. News reports provided anecdotal evidence that ... or oil and gas industries for their livelihoods were very ... their future. , Two decades of social science research ...
... (HealthDay News) -- Emergency room patients who are transported between ... into contact with health care workers who have not properly ... The researchers, reporting their findings online in the November issue ... study sheds light on the infectious risks associated with overcrowded ...
... Shellito, Chief of the Section of Pulmonary and Critical Care ... awarded approximately $9 million in grant funding to develop ... people with HIV infection. This potentially fatal illness is the ... 5-year grant was awarded by the National Heart Lung and ...
... HealthDay Reporter , WEDNESDAY, Oct. 5 (HealthDay News) -- ... world to personal computers, then the iPod, the iPhone and the ... He was 56. "Apple has lost a visionary ... being," the company said in a statement it posted on its ...
... -- The U.S. Food and Drug Administration announced late Thursday ... Cialis as a treatment for enlarged prostate. According to ... known as benign prostatic hyperplasia (BPH) -- is a "common ... that "more than half of men in their 60s, and ...
... -- The time between the start of substance abuse and ... for women, a U.S. government report shows. Researchers looked ... first time last year and found that the average length ... primarily being treated for was 15.6 years. The average ...
Cached Medicine News:Health News:Strong attachment to local communities made oil spill more stressful for many coastal residents 2Health News:ER Crowding May Encourage Poor Hand Hygiene 2Health News:LSUHSC awarded NIH grant to develop pneumonia vaccine 2Health News:Steve Jobs, Visionary Leader of Apple Inc., Dies at 56 2Health News:Steve Jobs, Visionary Leader of Apple Inc., Dies at 56 3Health News:FDA OKs Impotence Drug Cialis to Treat Enlarged Prostate 2
(Date:1/23/2015)... , Jan. 23, 2015 For the pharmaceutical industry, ... dealing with payers. Likewise, the importance of the managed markets ... only continue to grow as payer formularies and provider networks ... At the same time, managed markets leaders must ...
(Date:1/23/2015)... , Jan. 23, 2015 Research and Markets ... the "Urinary Catheters Market (Indwelling or Foley Catheters, ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... , At present, the global market for ...
(Date:1/23/2015)... ( www.medscope.org ), the leading provider of medical alert ... World magazine Connected World Award for its new ... used anywhere, anytime. The nomination was made by RacoWireless, ... MedScope, Landon Garner , Director of Marketing of ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2
... – Intercell AG (VSE,“ICLL”) has been informed by ... results of a Phase I study involving,in total ... of different doses of the Staphylococcus aureus,vaccine. , ... conserved protein,antigen discovered by Intercell’s Antigen Identification,Program (AIP®) ...
... 18, 2007 /PRNewswire-FirstCall/ -- A total,of 20 ... with,Schering-Plough's hepatitis products, including PEGINTRON(TM),(peginterferon alfa-2b) and ... C virus (HCV) infection, as well as,boceprevir ... inhibitor currently in Phase II clinical development, ...
Cached Medicine Technology:Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 2Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 2Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 4Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 5Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 6Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 7
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: